Concerto Biosciences®, a clinical-stage biotech company developing microbial products for therapeutics and consumer markets, today announced positive topline results from its first-in-human Phase 1b ...
Burcon NutraScience (TSX: BU), a global technology leader in plant-based protein innovation, announced that a study conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback